Literature DB >> 3031116

Characterization of the twenty-four hour secretion patterns of adrenocorticotropin and cortisol in normal women and patients with Cushing's disease.

J H Liu, R R Kazer, D D Rasmussen.   

Abstract

The episodic and circadian secretory patterns of ACTH and cortisol were studied in five patients with Cushing's disease (CD) and nine normal women by repetitive (every 20 min) venous blood sampling. In contrast to normal women, the 24-h transverse mean plasma ACTH levels were more than 3-fold greater (P less than 0.01), and the 24-h transverse mean serum cortisol levels were more than 2-fold higher (P less than 0.001) in the CD patients. Using a pulse detection algorithm, we found that the elevated ACTH levels in CD were accounted for, in part, by the more than 2-fold greater elevation in mean pulsatile ACTH amplitude (P less than 0.01), while the mean frequency of episodic ACTH and cortisol secretion was similar to that in normal subjects (10-12 episodes/24 h). Although a relatively close temporal relationship between ACTH and cortisol secretory episodes was found (r = 0.70 and 0.72, normal and CD groups, respectively), the increased ACTH pulse amplitude was not consistently associated with comparable cortisol pulses in CD patients. Circadian rhythms were identified for ACTH in two CD patients and for cortisol in all CD patients. The timing of the acrophases and nadirs for cortisol was not significantly altered compared to that in the normal group. After the noon meal, the normal postprandial elevation in cortisol was depressed or absent in the CD group. ACTH and cortisol responses to CRH in four CD patients were highly variable, but were not significantly different from those in normal subjects. These studies demonstrate that the elevated plasma ACTH levels in CD are sustained in part by increased ACTH pulse amplitude without significant alterations in pulse frequency. Despite the persistently high ACTH levels, the circadian variation of cortisol is maintained. The finding of an abnormal postprandial cortisol response in CD may provide an additional biological marker for CD.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031116     DOI: 10.1210/jcem-64-5-1027

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Folliculostellate cell network: a route for long-distance communication in the anterior pituitary.

Authors:  T Fauquier; N C Guérineau; R A McKinney; K Bauer; P Mollard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Endogenous ACTH concentration-cortisol secretion dose analysis unmasks decreased ACTH potency in Cushing's disease with restoration after successful pituitary adenomectomy.

Authors:  Ferdinand Roelfsema; Daniel M Keenan; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

Review 3.  Structural organization and biological relevance of oscillatory parathyroid hormone secretion.

Authors:  C P Schmitt; M Hömme; F Schaefer
Journal:  Pediatr Nephrol       Date:  2005-02-08       Impact factor: 3.714

4.  Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease.

Authors:  R van der Pas; C de Bruin; A M Pereira; J A Romijn; R T Netea-Maier; A R Hermus; P M Zelissen; F H de Jong; A J van der Lely; W W de Herder; S M Webb; S W J Lamberts; L J Hofland; R A Feelders
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

5.  Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis.

Authors:  Jamie J Walker; John R Terry; Stafford L Lightman
Journal:  Proc Biol Sci       Date:  2010-02-03       Impact factor: 5.349

6.  Adrenal Vein Cortisol to Metanephrine Ratio for Localizing ACTH-Independent Cortisol-Producing Adenoma: A Case Report.

Authors:  Rishi Raj; Philip A Kern; Neelima Ghanta; Edilfavia M Uy; Kamyar Asadipooya
Journal:  J Endocr Soc       Date:  2021-01-25

Review 7.  New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy.

Authors:  Maria Fleseriu; Stephan Petersenn
Journal:  J Neurooncol       Date:  2013-05-15       Impact factor: 4.130

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.